您的位置: 首页 > 农业专利 > 详情页

SINGLE NUCLEOTIDE POLYMORPHISM (SNP) TARGETING THERAPIES FOR THE TREATMENT OF HUNTINGTONS DISEASE
专利权人:
Neil Aronin
发明人:
Neil Aronin,Edith Pfister,Phillip D. Zamore
申请号:
US13263961
公开号:
US20120136039A1
申请日:
2010.04.08
申请国别(地区):
US
年份:
2012
代理人:
摘要:
The present invention relates to the discovery of (SNPs) significantly associated with Huntingtons disease (HD). The present invention utilizes RNA silencing technology (e.g. RNAi) against such SNPs optimally combined with select additional SNP targeting silencing agents, thereby resulting in an effective treatment of significantly-sized patient populations. Silencing agents having enhanced discriminatory properties are also featured.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充